Cytogenetics of bladder cancer

Kroft, 1994, Urinary bladder cancer: Mechanisms of development and progression, Lab Invest, 71, 158 Kakizoe, 1988, Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder, Cancer Res, 48, 2299 Sandberg, 1986, Chromosome changes in bladder cancer: Clinical and other correlations, Cancer Genet Cytogenet, 19, 163, 10.1016/0165-4608(86)90384-5 Gibas, 1984, Nonrandom chromosomal changes in transitional cell carcinoma of the bladder, Cancer Res, 44, 1257 Atkin, 1985, Cytogenetic study of ten carcinomas of the bladder: Involvement of chromosomes 1 and 11, Cancer Genet Cytogenet, 15, 253, 10.1016/0165-4608(85)90169-4 Gibas, 1986, A possible specific chromosome change in transitional cell carcinoma of the bladder, Cancer Genet Cytogenet, 19, 229, 10.1016/0165-4608(86)90051-8 Smeets, 1987, Chromosomal analysis of bladder cancer. III. Nonrandom alterations, Cancer Genet Cytogenet, 29, 29, 10.1016/0165-4608(87)90028-8 Vanni, 1988, Cytogenetic investigation on 30 bladder carcinomas, Cancer Genet Cytogenet, 30, 35, 10.1016/0165-4608(88)90090-8 Mitelman, 1994 Babu, 1987, Tumor behaviour in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology, Cancer Res, 47, 6800 Powell, 1990, Apparent correlation of sex chromosome loss and disease course in urothelial cancer, Cancer Genet Cytogenet, 50, 97, 10.1016/0165-4608(90)90242-3 Presti, 1991, Molecular genetic alterations in superficial and locally advanced human bladder cancer, Cancer Res, 51, 5405 Hopman, 1989, Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization, Am J. Pathol, 135, 1105 Voorter, 1995, Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization, Am J Pathol, 146, 1341 Kovacs, 1986, Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer, J Cancer Res Clin Oncol, 110, 249, 10.1007/BF00399284 Berger, 1986, Chromosome in kidney, ureter and bladder cancer, Cancer Genet Cytogenet, 23, 1, 10.1016/0165-4608(86)90145-7 Vanni, 1986, Letter to the editor, Cancer Res, 46, 4873 Smeets, 1993, Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer, Cancer Genet Cytogenet, 71, 97, 10.1016/0165-4608(93)90208-4 Bernues, 1993, A case of transitional cell carcinoma of the bladder with a del(9) (q11q21.2), Cancer Genet Cytogenet, 69, 76, 10.1016/0165-4608(93)90120-B Waldman, 1991, Centromeric number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer, Cancer Res, 51, 3807 Hopman, 1991, Numerical chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization, Cancer Res, 51, 644 Matsuyama, 1994, Nonrandom numerical aberrations of chromosomes 7, 9 and 10 in DNA- diploid bladder cancer, Cancer Genet Cytogenet, 77, 118, 10.1016/0165-4608(94)90226-7 Sauter, 1995, Chromosome 9 loss detected by fluorescence in situ hybridization in bladder cancer, Int J Cancer, 64, 99, 10.1002/ijc.2910640205 Olumi, 1990, Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas, Cancer Res, 50, 7081 Tsai, 1990, Allelic losses of chromosome 9, 11 and 17 in human bladder cancer, Cancer Res, 50, 44 Dalbagni, 1993, Genetic alterations in bladder cancer, Lancet, 342, 469, 10.1016/0140-6736(93)91595-D Spruck, 1994, Two molecular pathways to transitional cell carcinoma of the bladder, Cancer Res, 54, 784 Orlow, 1994, Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors, Cancer Res, 54, 2848 Knowles, 1994, Allelotype of human bladder cancer, Cancer Res, 54, 531 Cairns, 1993, Preliminary mapping of the deleted region of chromosome 9 in bladder cancer, Cancer Res, 53, 1230 Ruppert, 1993, Evidence for two bladder cancer suppressor loci on human chromosome 9, Cancer Res, 53, 5093 Keen, 1994, Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder, Oncogene, 9, 2083 Devlin, 1994, Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA, Oncogene, 9, 2757 Knowles, 1995, Molecular genetics of bladder cancer, Br J Urol, 75, 57 Williamson, 1995, p16(CDKN2) is a major deletion target at 9p21 in bladder cancer, Hum Mol Genet, 4, 1569, 10.1093/hmg/4.9.1569 Orlow, 1995, Deletion of the p16 and p15 genes in human bladder tumors, JNCI, 87, 1524, 10.1093/jnci/87.20.1524 Southgate, 1995, Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines, Br J Cancer, 72, 1214, 10.1038/bjc.1995.488 Gruis, 1995, Genetic evi dence in melanoma and bladder cancer that p16 and p53 function in two separate pathways of tumor suppression, Am J Pathol, 146, 1199 Tanaka, 1995, Gensolin: A candidate tumor suppressor of human bladder cancer, Cancer Res, 55, 3328 Williamson, 1994, The spectrum of TP53 mutations in bladder carcinoma, Genes Chromosom Cancer, 9, 108, 10.1002/gcc.2870090206 Greenblatt, 1994, Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis, Cancer Res, 54, 4855 Sidransky, 1991, Identification of p53 mutations in bladder cancers and urine samples, Science, 252, 706, 10.1126/science.2024123 Nemoto, 1995, Numerical chromosome aberrations in bladder cancer detected by in situ hybridization, Br J Urol, 75, 470, 10.1111/j.1464-410X.1995.tb07267.x DerKinderen, 1988, Non-ocular cancer in patients with hereditary, retinoblastoma and their relatives, Int J Cancer, 41, 499, 10.1002/ijc.2910410405 Cairns, 1991, Loss of heterozygosity at the Rb locus in frequent and correlates with muscle invasion in bladder cancer, Oncogene, 6, 2305 Xu, 1993, Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression, Int J Cancer, 53, 781, 10.1002/ijc.2910530513 Cordon-Cardo, 1992, Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer, JNCI, 84, 1251, 10.1093/jnci/84.16.1251 Miyamoto, 1995, Ratinoblastoma gene mutations in primary human bladder cancer, Br J Cancer, 71, 831, 10.1038/bjc.1995.160 Vanni, 1985, Derivative marker chromosome in bladder carcinoma, Cancer Genet Cytogenet, 16, 289, 10.1016/0165-4608(85)90235-3 Vanni, 1987, Cytogenetics of bladder cancer: Rearrangements of the short arm of chromosome 11, Cancer Detect Prev, 10, 401 Voorter, 1996, Loss of chromosome 11 and 11p/q imbalances in bladder cancer detected by fluorescence in situ hybridization, Int J Cancer, 65, 301, 10.1002/(SICI)1097-0215(19960126)65:3<301::AID-IJC4>3.0.CO;2-3 Fearon, 1985, Loss of genes on the short arm of chromosome 11 in bladder cancer, Nature, 318, 377, 10.1038/318377a0 Shipman, 1993, Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma, Hum Genet, 91, 455, 10.1007/BF00217771 Reznikoff, 1993, A molecular genetic model of human bladder carcinogenesis, Sem Cancer Biol, 4, 143 Ohta, 1996, The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint is abnormal in digestive tract cancers, Cell, 587–597 Perucca, 1990, Molecular genetics of human bladder carcinomas, Cancer Genet Cytogenet, 49, 143, 10.1016/0165-4608(90)90136-X Brewster, 1994, Loss of heterozygosity on chromosome 18q is associated with muscle invasive transitional cell carcinoma of the bladder, Br J Cancer, 70, 697, 10.1038/bjc.1994.376 Kallionemi, 1995, Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization, Genes Chromosom Cancer, 12, 213, 10.1002/gcc.2870120309 Knowles, 1993, Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction length polymorphisms and microsatellite polymorphisms, Oncogene, 8, 1357 Elder, 1994, Deletion of two regions on chromosome 4 in bladder carcinoma: Definition of a critical 750kb region at 4p16.3, Oncogene, 9, 3433 Babu, 1989, Chromosome 21822 deletion. A specific chromosome change in a new bladder cancer subgroup, Cancer Genet Cytogenet, 38, 127, 10.1016/0165-4608(89)90173-8 Chang, 1995, Novel suppressor loci on chromosome 14q in primary bladder cancer, Cancer Res, 55, 3246 Atkin, 1991, Numerical chromosome changes in 165 malignant tumors. Evidence of a nonrandom distribution of normal chromosomes, Cancer Genet Cytogenet, 52, 113, 10.1016/0165-4608(91)90061-X Wang, 1994, Nonrandom changes of chromosome 10 in bladder cancer. Detection by FISH to interphase nuclei, Cancer Genet Cytogenet, 73, 8, 10.1016/0165-4608(94)90175-9 Matsuyama, 1994, Nonrandom numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer, Cancer Genet Cytogenet, 77, 118, 10.1016/0165-4608(94)90226-7 Atkin, 1990, 5q deletion. The sole chromosomal change in a carcinoma of the bladder, Cancer Genet Cytogenet, 46, 129, 10.1016/0165-4608(90)90019-7 Berrozpe, 1990, Trisomy 7 may be a primary change in noninvasive transitional cell carcinoma of the bladder, Cancer Genet Cytogenet, 50, 9, 10.1016/0165-4608(90)90232-Y Sandberg, 1986, Chromosome change in transitional cell carcinoma of the ureter, Cancer Genet Cytogenet, 19, 335, 10.1016/0165-4608(86)90063-4 Gibas, 1987, Trisomy 7 and i(5p) in a transitional cell carcinoma of the ureter, Cancer Genet Cytogenet, 25, 369, 10.1016/0165-4608(87)90200-7 Vanni, 1989, Trisomy 7 in a case of transitional cell carcinoma of the kidney, Cancer Genet Cytogenet, 41, 149, 10.1016/0165-4608(89)90120-9 Bardi, 1991, Trisomy 7 in short-term cultures of colorectal adenocarcinomas, Genes Chrom Cancer, 3, 149, 10.1002/gcc.2870030211 Lee, 1987, Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue, Cancer res, 47, 6349 Elfvig, 1990, Trisomy 7, trisomy 10 and loss of the Y chromosome in short-term cultures of normal kidney tissue, Cancer Genet Cytogenet, 53, 123, 10.1159/000132910 Heim, 1989, Trisomy 7 and sex chromosome loss in human brain tissue, Cancer Genet Cytogenet, 52, 136, 10.1159/000132863 Dal Cin, 1992, Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue, PNAS, 89, 9744, 10.1073/pnas.89.20.9744 Atkin, 1986, Chromosome 1 aberrations in cancer, Cancer Genet Cytogenet, 21, 279, 10.1016/0165-4608(86)90206-2 Tyrkus, 1992, Cytogenetic studies of carcinoma in situ of the bladder: Prognostic implications, J Urol, 148, 44, 10.1016/S0022-5347(17)36504-7 Poddighe, 1992, Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: Interphase cytogenetics combining a centromeric, telomeric, and library DNA probe, Cancer Res, 52, 4929 Paraskeva, 1989, Possible involvement of chromosome 1 in in vitro immortalization: evidence from progression of a human adenoma-derived cell line in vitro, Int J Cancer, 43, 743, 10.1002/ijc.2910430434 Sandberg, 1992, Chromosome changes in early bladder neoplasms, J Cell Biochem (Suppl), 161, 76, 10.1002/jcb.240501317 Sandberg, 1994, Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer, J Urol, 151, 545, 10.1016/S0022-5347(17)35014-0 Sauter, 1995, Y chromosome loss detected by FISH in bladder cancer, Cancer Genet Cytogenet, 82, 163, 10.1016/0165-4608(95)00030-S Betz, 1996, FISH studies of the Y chromosome in male urinary cells, Cancer Genet Cytogenet, 88, 155, 10.1016/0165-4608(95)00283-9 Sauter, 1995, c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization, Am J Pathol, 146, 1131 Coombs, 1991, Amplification and overexpression of c-erBB2 in transitional cell carcinoma of the urinary bladder, Br J Cancer, 63, 601, 10.1038/bjc.1991.139 Sauter, 1993, Heterogeneity of erbB-2 gene amplification in bladder cancer, Cancer Res, 53, 2199 Ye, 1993, Correlation between the expression of oncogenes ras and c-erbB2 and the biological behaviour of bladder tumors, Urol Res, 21, 39, 10.1007/BF00295190 Meloni, 1993, A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings and tumors, Cancer Genet Cytogenet, 71, 105, 10.1016/0165-4608(93)90015-E